Mass Tort Lead Aggregator Economics: Reconciling Bulk-Purchased Claims Against Blended CPL

Mass tort lead aggregator economics get reported the same way most PI marketing gets reported: as a single cost-per-lead number. According to Mass Tort Ad Agency's continuously updated benchmark tracker, the blended cost per lead across 11 active tort campaigns currently sits at $128.05, based on $781,374 in tracked 30-day Meta ad spend. That number looks manageable. It also tells a firm almost nothing about whether the leads behind it are worth buying.

Mature mass tort campaigns in the settlement phase, where every plaintiff firm and PI aggregator is competing for the same claimant pool, can run $150 to $350 per qualified lead according to the same source. The gap between a $128 blended average and a $350 mature-tort lead is exactly the kind of variance that mass tort lead aggregator economics has to reconcile — not average away.

Why Cost Per Lead Alone Doesn't Show True Cost

Mass Tort Ad Agency's own benchmark analysis makes the point directly: a firm paying $150 per qualified lead but converting only 30 percent to signed cases has a true cost per signed case of $500. A firm paying $200 per lead but converting 70 percent has a true cost per signed case of just $286. The lower sticker price loses. This is the mass tort version of the reconciliation gap already covered for retail PI leads in Cost Per Signed Case — the CPL number and the true acquisition cost are two different figures, and only one of them determines profitability.

The Shared-Lead Problem Aggregators Rarely Disclose

According to Mohr Marketing's 2026 mass tort lead generation roadmap, when a lead aggregator sells the same claimant's information to multiple firms simultaneously, the claimant ends up contacted by several firms at once — creating a high-friction experience that reduces the odds any single firm converts that lead into a signed case. The same source notes that fewer than 40 percent of plaintiff firms accurately measure their ROI beyond the basic cost-per-lead metric, meaning most firms buying shared mass tort leads have no visibility into how much that sharing is actually costing them in lost conversions.

This is precisely the kind of cost that CDAI's lead-distribution reconciliation is built to trace — connecting aggregator platforms like Boberdoo and inbound telephony data from Ringba back to the eventual signed-case outcome, the same adapter mechanism covered in the True CAC reconciliation guide, extended to bulk-purchased claim leads rather than direct-response campaigns.

What Mass Tort Lead Aggregator Economics Requires

• 1
  Every purchased lead traced to its actual conversion outcome, not just its purchase price, so the true cost per signed case is known rather than assumed from the sticker CPL.
• 2
  Exclusivity status tracked per lead source. A shared-lead vendor and an exclusive-lead vendor showing similar CPL numbers can have very different true acquisition costs once conversion rate is reconciled.
• 3
  Vendor-level directives, not just campaign-level ones. The Scale, Hold, Cut, Pause framework applies as much to a lead aggregator relationship as it does to an ad campaign — once true cost per signed case is known per vendor.

Mass tort lead aggregator economics isn't a reason to avoid aggregators — it's the reconciliation that determines which aggregator relationships are actually worth keeping, and which ones are hiding a much higher true cost behind a competitive-looking CPL.